Market Research Logo

Progenics Pharmaceuticals, Inc.

Progenics Pharmaceuticals, Inc. - Strategy and SWOT Report,

- is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Features:

  • Detailed information on Progenics Pharmaceuticals, Inc. required for business and competitor intelligence needs
  • A study of the major internal and external factors affecting Progenics Pharmaceuticals, Inc. in the form of a SWOT analysis
  • An in-depth view of the business model of Progenics Pharmaceuticals, Inc. including a breakdown and examination of key business segments
  • Intelligence on Progenics Pharmaceuticals, Inc.’s mergers and acquisitions (M&A), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
  • News about Progenics Pharmaceuticals, Inc., such as business expansion, restructuring, and contract wins
  • Large number of easy-to-grasp charts and graphs that present important data and key trends
Highlights:

Progenics Pharmaceuticals (Progenics or 'the company') is a biopharmaceutical company focused on the development and commercialization of therapeutic products for the treatment of cancer. The company operates in the US, where it is headquartered in Tarrytown, New York. It employed 57 people as on December 31, 2014.Reasons to Purchase:

  • Gain understanding of Progenics Pharmaceuticals, Inc. and the factors that influence its strategies
  • Track strategic initiatives of the company and latest corporate news and actions
  • Assess Progenics Pharmaceuticals, Inc. as a prospective partner, vendor or supplier
  • Support sales activities by understanding your customers' businesses better
  • Stay up to date on Progenics Pharmaceuticals, Inc.’s business structure, strategy and prospects

  • Company Snapshot
    Progenics Pharmaceuticals, Inc.: Company Overview
    Progenics Pharmaceuticals, Inc.: Overview and Key Facts
    Progenics Pharmaceuticals, Inc.: Overview
    Progenics Pharmaceuticals, Inc.: Key Facts
    Progenics Pharmaceuticals, Inc.: Key Employees
    Progenics Pharmaceuticals, Inc.: Key Employee Biographies
    Progenics Pharmaceuticals, Inc.: Major Products and Services
    Progenics Pharmaceuticals, Inc.: Company History
    Progenics Pharmaceuticals, Inc.: Management Statement
    Progenics Pharmaceuticals, Inc.: Locations and Subsidiaries
    Progenics Pharmaceuticals, Inc.: Key Competitors
    Progenics Pharmaceuticals, Inc.: Company Analysis
    Progenics Pharmaceuticals, Inc.: Business Description
    Progenics Pharmaceuticals, Inc.: SWOT Analysis
    Progenics Pharmaceuticals, Inc.: SWOT Overview
    Progenics Pharmaceuticals, Inc.: Strengths
    Progenics Pharmaceuticals, Inc.: Weaknesses
    Progenics Pharmaceuticals, Inc.: Opportunities
    Progenics Pharmaceuticals, Inc.: Threats
    Progenics Pharmaceuticals, Inc.: Corporate Financial Deals Activity
    Progenics Pharmaceuticals, Inc.: Financial Deals Overview
    Progenics Pharmaceuticals, Inc.: Targets and Partners
    Progenics Pharmaceuticals, Inc.: Top Deals 2011 - 2015YTD*
    Progenics Pharmaceuticals, Inc.: Advisors
    Progenics Pharmaceuticals, Inc.: Top Legal Advisors
    Progenics Pharmaceuticals, Inc.: Top Financial Advisors
    Progenics Pharmaceuticals, Inc.: Mergers and Acquisitions
    Progenics Pharmaceuticals, Inc.: Capital Raising
    Progenics Pharmaceuticals, Inc.: Partnership
    Progenics Pharmaceuticals, Inc.: Divestments
    Progenics Pharmaceuticals, Inc.: Recent Developments
    Progenics Pharmaceuticals, Inc.: News and Events Summary
    Progenics Pharmaceuticals, Inc.: Contracts
    Progenics Pharmaceuticals, Inc.: Corporate Governance
    Progenics Pharmaceuticals, Inc.: Financial Performance
    Progenics Pharmaceuticals, Inc.: Regulatory and Legal Events
    Progenics Pharmaceuticals, Inc.: Research & Development
    Appendix
    Contact Us
    Methodology
    Definitions
    About Market Line
    List of Tables
    Table 1: Progenics Pharmaceuticals, Inc.: Key Facts
    Table 2: Progenics Pharmaceuticals, Inc.: Key Employees
    Table 4: Progenics Pharmaceuticals, Inc.: Key Competitors
    Table 5: Progenics Pharmaceuticals, Inc.: Deal Activity by Deal Type - Volume (TTM*)
    Table 6: Progenics Pharmaceuticals, Inc.: M&A Activity by Geography (TTM*)
    Table 7: Progenics Pharmaceuticals, Inc.: Deal Activity by Deal Type - Volume (2011 - YTD*2015)
    Table 8: Progenics Pharmaceuticals, Inc.: M&A Average Deal Size - Value (US$m)
    Table 9: Progenics Pharmaceuticals, Inc.: Targets and Partners
    Table 10: Progenics Pharmaceuticals, Inc.: Top Deals 2011 - 2015YTD*
    Table 11: Progenics Pharmaceuticals, Inc.: Legal Advisor Ranking by Value (US$m)
    Table 12: Progenics Pharmaceuticals, Inc.: Financial Advisor Ranking by Value (US$m)
    Table 13: Progenics Pharmaceuticals, Inc.: M&A Volume and Value Trend (2011 - YTD*2015)
    Table 14: Progenics Pharmaceuticals, Inc.: M&A Activity by Geography (2011 - YTD*2015)
    Table 15: Progenics Pharmaceuticals, Inc.: Capital Raising Volume and Value Trend (2011 - YTD*2015)
    Table 16: Progenics Pharmaceuticals, Inc.: Capital Raising by Deal Type (2011 - YTD*2015)
    Table 17: Progenics Pharmaceuticals, Inc.: Partnership Volume and Value Trend (2011 - YTD*2015)
    Table 18: Progenics Pharmaceuticals, Inc.: Partnership Trend by Deal Type (2011 - YTD*2015)
    Table 19: Progenics Pharmaceuticals, Inc.: Divestments Volume and Value Trend (2011 - YTD*2015)
    Table 20: Progenics Pharmaceuticals, Inc.: Divestments by Geography (2011 - YTD*2015)
    Table 21: Progenics Pharmaceuticals, Inc.: News and Events Summary
    Table 22: Progenics Pharmaceuticals, Inc.: Contracts
    Table 23: Progenics Pharmaceuticals, Inc.: Corporate Governance
    Table 24: Progenics Pharmaceuticals, Inc.: Financial Performance
    Table 25: Progenics Pharmaceuticals, Inc.: Regulatory and Legal Events
    Table 26: Progenics Pharmaceuticals, Inc.: Research & Development
    List of Figures
    Figure 1: Progenics Pharmaceuticals, Inc.: Deal Activity by Deal Type - Volume (TTM*)
    Figure 2: Progenics Pharmaceuticals, Inc.: M&A Activity by Geography (TTM*)
    Figure 3: Progenics Pharmaceuticals, Inc.: Deal Activity by Deal Type - Volume (2011 - YTD*2015)
    Figure 4: Progenics Pharmaceuticals, Inc.: M&A Average Deal Size - Value (US$m)
    Figure 5: Progenics Pharmaceuticals, Inc.: M&A Volume and Value Trend (2011 - YTD*2015)
    Figure 6: Progenics Pharmaceuticals, Inc.: M&A Activity by Geography (2011 - YTD*2015)
    Figure 7: Progenics Pharmaceuticals, Inc.: Capital Raising Volume and Value Trend (2011 - YTD*2015)
    Figure 8: Progenics Pharmaceuticals, Inc.: Capital Raising by Deal Type (2011 - YTD*2015)
    Figure 9: Progenics Pharmaceuticals, Inc.: Partnership Volume and Value Trend (2011 - YTD*2015)
    Figure 10: Progenics Pharmaceuticals, Inc.: Partnership Trend by Deal Type (2011 - YTD*2015)
    Figure 11: Progenics Pharmaceuticals, Inc.: Divestments Volume and Value Trend (2011 - YTD*2015)
    Figure 12: Progenics Pharmaceuticals, Inc.: Divestments by Geography (2011 - YTD*2015)

    Download our eBook: How to Succeed Using Market Research

    Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

    Download eBook

    Share this report